Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3108229/0/en/Abeona-Therapeutics-Announces-Option-Exercise-by-Beacon-Therapeutics-for-Novel-AAV204-Capsid-for-Ophthalmology-Gene-Therapy.html
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095785/30580/en/Beacon-Therapeutics-Strengthens-Leadership-Team-with-the-Appointment-of-Dr-Daniel-Chung-as-Chief-Medical-Officer.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075349/30580/en/Beacon-Therapeutics-Announces-Positive-Phase-2-Interim-6-Month-Data-from-DAWN-Trial-of-Laru-zova-in-Patients-with-X-linked-Retinitis-Pigmentosa-XLRP-at-ARVO-2025.html
24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beacon-therapeutics-announces-arvo-2025-presentation-on-preliminary-6-month-data-from-its-phase-2-dawn-trial-of-laru-zova-in-patients-with-x-linked-retinitis-pigmentosa-xlrp-302437302.html
15 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beacon-therapeutics-announces-positive-24-month-data-from-phase-2-skyline-trial-of-agtc-501-in-patients-with-x-linked-retinitis-pigmentosa-302275688.html
19 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beacon-therapeutics-presents-36-month-interim-results-from-phase-i2-horizon-trial-of-agtc-501-in-patients-with-xlrp-302252375.html
ABOUT THIS PAGE